Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel
Last Updated: Thursday, July 10, 2025
Investigators conducted whole-genome shotgun sequencing on stool samples from patients with multiple myeloma undergoing idecabtagene vicleucel (ide-cel) administration. They found a significant decrease in bacterial diversity following ide-cel infusion. Additionally, there were significant differences in bacterial composition, which were linked to therapy response and toxicities.
Advertisement
News & Literature Highlights